Riskpilot← Back to searchSign inGet full accessSENTRUM LEGESENTER SKIEN AS
ASActiveOrg 916021739Henrik Ibsens Gate 6, 3724 SkienGeneral medical practice activities · NACE 8621Est. 20157 employees
Revenue 2025
NOK 3,9M
+12% vs 2024
EBITDA margin
0.9%
+138% vs 2024
Equity ratio
14.1%
Financial strength
Net profit 2025
NOK 2K
+102% vs 2024
| Revenue | NOK 3,9M | +12% |
| EBITDA | NOK 33K | +138% |
| Net profit | NOK 2K | +102% |
| Total assets | NOK 528K | +34% |
| Equity | NOK 74K | +3% |
| Employees | 7 | — |
Legal name
SENTRUM LEGESENTER SKIEN AS
Org number
916021739
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
5. oktober 2015
Share capital
NOK 40 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive legesenter i skien kommune, investering i eiendom og andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Henrik Ibsens Gate 6, 3724 Skien
Phone
+4735506600
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 197 | 3 444 | 3 556 | 3 475 | 3 897 |
| Staff expenses | −1 724 | −1 906 | −1 752 | −1 821 | −2 028 |
| EBITDA | 172 | −159 | 216 | −89 | 33 |
| Depreciation & amort. | −32 | −2 | −23 | −31 | −31 |
| EBIT | 140 | −161 | 193 | −120 | 2 |
| Net financials | 0 | −0 | 1 | −0 | 0 |
| Profit before tax | 140 | −161 | 193 | −120 | 2 |
| Tax | 17 | −0 | −0 | −0 | −0 |
| Net profit | 123 | −161 | 193 | −120 | 2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 491 | 483 | 688 | 393 | 528 |
| Equity | 160 | −2 | 192 | 72 | 74 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 331 | 485 | 496 | 321 | 453 |
| Total debt | 331 | 485 | 496 | 321 | 453 |
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
20212025
Equity ratio
14.1%
This company
38.2%
Market median
-63% vs market
20212025
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20212025
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20212025
Asset turnover
7.38×
This company
1.12×
Market median
+559% vs market
20212025
Debt / equity
6.09×
This company
0.62×
Market median
-882% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LB Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (1) | ||
| Board of Directors | 2018 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SENTRUM LEGESENTER SKIEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Berit Gaathaug | Chief Executive Officer | 0 companies |
| Saharat Subphatkul Laksana | Board of Directors | 0 companies |
| Elise Charlotte Melkild | Board of Directors | 0 companies |
| Eirik Knapskog | Board of Directors | 0 companies |
| Sven Tollefsen | Board of Directors | 0 companies |
| Sigurd Haugan Danielsen | Chairman | 0 companies |